Inflammatory Breast Carcinoma in Magnetic Resonance Imaging. A Comparison with Locally Advanced Breast Cancer

Academic Radiology

Volumn 15, Issue 2, 2008, Pages 209-221

  Renz, Diane M ^a   Baltzer, Pascal A T ^a   Böttcher, Joachim ^a   Thaher, Fady ^a   Gajda, Mieczyslaw ^a   Camara, Oumar ^a   Runnebaum, Ingo B ^a   Kaiser, Werner A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

dynamics; Inflammatory breast carcinoma; locally advanced breast cancer; morphology; MR mammography

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER INVASION; COMPARATIVE STUDY; CONTROLLED STUDY; EDEMA; FEMALE; HUMAN; INFLAMMATORY DISEASE; LIGAMENT; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SKINFOLD;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM INVASIVENESS;

EID: 38149113409     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2007.09.011     Document Type: Article

References (48)

1. Jaiyesimi I.A., Buzdar A.U., and Hortobagyi G. Inflammatory breast cancer: a review. J Clin Oncol 10 (1992) 1014-1024
2. Hance K.W., Anderson W.F., Devesa S.S., et al. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst 97 (2005) 966-975
3. Rosen P.P. Inflammatory carcinoma. In: Rosen P.P. (Ed). Rosen's breast pathology. ed 2 (2001), Lippincott Williams & Wilkins, Philadelphia, PA 676-687
4. Amparo R.S., Angel C.D., Ana L.H., et al. Inflammatory breast carcinoma: pathological or clinical entity?. Breast Cancer Res Treat 64 (2000) 269-273
5. Wilke D., Colwell B., and Dewar R. Inflammatory breast carcinoma: comparison of survival of those diagnosed clinically, pathologically, or with both features. Am Surg 64 (1998) 428-431
6. Lee K.W., Chung S.Y., Yang I., et al. Inflammatory breast cancer: imaging findings. Clin Imaging 29 (2005) 22-25
7. Belli P., Costantini M., Romani M., et al. Role of magnetic resonance imaging in inflammatory carcinoma of the breast. Rays 27 (2002) 299-305
8. Günhan-Bilgen I., Üstün E.E., and Memis A. Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology 223 (2002) 829-838
9. Kushwaha A.C., Whitman G.J., Stelling C.B., et al. Primary inflammatory carcinoma of the breast: retrospective review of mammographic findings. AJR Am J Roentgenol 174 (2000) 535-538
10. Orel S.G., and Schnall M.D. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 220 (2001) 13-30
11. Kuhl C.K. Current status of breast MR imaging: part 2. Clinical applications. Radiology 244 (2007) 672-691
12. Chou C.P., Wu M.T., Chang H.T., et al. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study. Acad Radiol 14 (2007) 561-573
13. Berg W.A., Gutierrez L., NessAiver M.S., et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233 (2004) 830-849
14. Friedman P., Sanders L., Russo J., et al. Detection and localization of occult lesions using breast magnetic resonance imaging: initial experience in a community hospital. Acad Radiol 12 (2005) 728-738
15. Kaiser W.A., and Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 170 (1989) 681-686
16. Heywang-Köbrunner S.H., Viehweg P., Heinig A., et al. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 24 (1997) 94-108
17. Kuhl C.K., Mielcareck P., Klaschik S., et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 211 (1999) 101-110
18. Sherif H., Mahfouz A.E., Oellinger H., et al. Peripheral washout sign on contrast-enhanced MR images of the breast. Radiology 205 (1997) 209-213
19. Daniel B.L., Yen Y.F., Glover G.H., et al. Breast disease: dynamic spiral MR imaging. Radiology 209 (1998) 499-509
20. Mussurakis S., Buckley D.L., Drew P.J., et al. Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours. Clin Radiol 52 (1997) 516-526
21. Baum F., Fischer U., Vosshenrich R., et al. Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol 12 (2002) 1087-1092
22. Chen W., Giger M.L., and Bick U. A fuzzy c-means (FCM)-based approach for computerized segmentation of breast lesions in dynamic contrast-enhanced MR images. Acad Radiol 13 (2006) 63-72
23. Kuhl C.K., Klaschik S., Mielcarek P., et al. Do T2-weighted pulse sequences help with the differential diagnosis of enhancing lesions in dynamic breast MRI?. J Magn Reson Imaging 9 (1999) 187-196
24. Fischer D.R., Wurdinger S., Böttcher J., et al. Further signs in the evaluation of magnetic resonance mammography: a retrospective study. Invest Radiol 40 (2005) 430-435
25. Malich A., Fischer D.R., Wurdinger S., et al. Potential MRI interpretation model: differentiation of benign from malignant breast masses. AJR Am Roentgenol 185 (2005) 964-970
26. Rieber A., Tomczak R.J., Mergo P.J., et al. MRI of the breast in the differential diagnosis of mastitis versus inflammatory carcinoma and follow-up. J Comput Assist Tomogr 21 (1997) 128-132
27. Tomczak R.J., Rieber A., Zeitler H., et al. The value of MR-mammography at 1.5 tesla in the differential diagnosis of non-puerperal mastitis and inflammatory breast carcinoma. Rofo 165 (1996) 148-151
28. Yasumura K., Ogawa K., Ishikawa H., et al. Inflammatory carcinoma of the breast: characteristic findings of MR imaging. Breast Cancer 4 (1997) 161-169
29. Anderson W.F., Chu K.C., and Chang S. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?. J Clin Oncol 21 (2003) 2254-2259
30. Lerebours F., Bieche I., and Lidereau R. Update on inflammatory breast cancer. Breast Cancer Res 7 (2005) 52-58
31. Giordano S.H. Update on locally advanced breast cancer. Oncologist 8 (2003) 521-530
32. Pfleiderer S.O.R., Sachse S., Sauner D., et al. Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res 6 (2004) R232-R238
33. Rieber A., Nüssle K., Merkle E., et al. MR mammography: influence of menstrual cycle on the dynamic contrast enhancement of fibrocystic disease. Eur Radiol 9 (1999) 1107-1112
34. Schauer A., Korabiowska M., Kellner S., et al. Grading system for breast cancer. Anticancer Res 18 (1998) 2139-2144
35. American College of Radiology (ACR). Breast imaging reporting and data system (BI-RADS) atlas (2003), American College of Radiology, Reston, VA
36. Fischer D.R., Baltzer P., Malich A., et al. Is the "blooming sign" a promising additional tool to determine malignancy in MR mammography?. Eur Radiol 14 (2004) 394-401
37. Penn A., Thompson S., Brem R., et al. Morphologic blooming in breast MRI as a characterization of margin for discriminating benign from malignant lesions. Acad Radiol 13 (2006) 1344-1354
38. Buadu L.D., Murakami J., Murayama S., et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 200 (1996) 639-649
39. Renz D.M., Baltzer P.A.T., Böttcher J., et al. New signs of tumors in magnetic resonance imaging. Eur Radiol 16 (2006) E80-E82
40. Macéa J.R., and Fregnani J.H.T.G. Anatomy of the thoracic wall, axilla and breast. Int J Morphol 24 (2006) 691-704
41. Mahfouz A.E., Sherif H., Saad A., et al. Gadolinium-enhanced MR angiography of the breast: is breast cancer associated with ipsilateral higher vascularity?. Eur Radiol 11 (2001) 965-969
42. Droulias C.A., Sewell C.W., McSweeney M.B., et al. Inflammatory carcinoma of the breast: a correlation of clinical, radiologic and pathologic findings. Ann Surg 184 (1976) 217-222
43. Guinebretière J.M., Menet E., Tardivon A., et al. Normal and pathological breast, the histological basis. Eur J Radiol 54 (2005) 6-14
44. Dirix L.Y., Dam P.V., Prové A., et al. Inflammatory breast cancer: current understanding. Curr Opin Oncol 18 (2006) 563-571
45. Dvorak H.F., Dickersin G.R., Dvorak A.M., et al. Human breast carcinoma: fibrin deposits and desmoplasia. Inflammatory cell type and distribution. Microvasculature and infarction. J Natl Cancer Inst 67 (1981) 335-345
46. Brown L.F., Guidi A.J., Schnitt S.J., et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 5 (1999) 1041-1056
47. Van Goethem M., Tjalma W., Schelfout K., et al. Magnetic resonance imaging in breast cancer. Eur J Surg Oncol 32 (2006) 901-910
48. Crowe D.J., Helvie M.A., and Wilson T.E. Breast infection. Mammographic and sonographic findings with clinical correlation. Invest Radiol 30 (1995) 582-587